Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel

Cancer Drug Resistance(2020)10.20517/cdr.2019.116Source: DataRank Database

Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel is a research paper published in Cancer Drug Resistance (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

uniprot nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.55)OA: goldTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Daniel Worroll ORCID,Giuseppe Galletti ORCID,Shelly Schuster,Sarina A. Piha‐Paul ORCID,Paraskevi Giannakakou ORCID

Live enrichment

PubMed:33062959 PMC:PMC7556717 OpenAlex:https://openalex.org/W3020418888

NCI NIH HHS

Grant: R01 CA137020

NCATS NIH HHS

Grant: UL1 TR002384

NCI NIH HHS

Grant: T32 CA062948

NCI NIH HHS

Grant: R01 CA179100

NCI NIH HHS

Grant: F32 CA220988

NCI NIH HHS

Grant: R21 CA216800

FWCI

0.55

Citation Percentile

0.7%

Citation Trend

2020

2022

2023

2024

goldLicense: cc-by

journalhttps://cdrjournal.com/article/download/3425

GOLDhttps://cdrjournal.com/article/download/3425

publisherhttps://cdrjournal.com/article/download/3425

journalhttps://doi.org/10.20517/cdr.2019.116

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33062959

Fields of Study

Prostate Cancer Treatment and ResearchCancer Cells and MetastasisCancer, Stress, Anesthesia, and Immune ResponseMedicineChemistry

Keywords

TaxaneDocetaxelProstate cancerMedicineCabazitaxelOncologyDrugCancerMicrotubulePaclitaxelInternal medicineCancer researchPharmacologyBiologyBreast cancerAndrogen deprivation therapyMicrotubulesBiomarkersTaxanesCastration-resistant Prostate CancerCirculating Tumor CellsLiquid Biopsy

Sustainable Development Goals

SDG 0: Good health and well-being